SIM
SKBI

Spark Investment Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Spark Investment Management’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$39K – 836
2015
Q2 		$39K Sell
15,000
-2,000
-12% -$6.85K 0.01% 637
2015
Q1 		$66K Sell
17,000
-4,100
-19% -$17.4K 0.01% 654
2014
Q4 		$89K Sell
21,100
-300
-1% -$1.29K 0.02% 592
2014
Q3 		$89K Buy
21,400
+6,300
+42% +$34.2K 0.01% 602
2014
Q2 		$110K Buy
15,100
+600
+4% +$3.58K 0.02% 555
2014
Q1 		$94K Buy
+14,500
New +$73.4K 0.01% 615

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Spark Investment Management's SKBI Position: Q3 2015 in Review

Spark Investment Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 15,000 shares — an estimated $39K sold.

Spark Investment Management first reported a position in SKBI in Q1 2014 and held it in 6 quarters. The position peaked at $110K in Q2 2014. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

  • Spark Investment Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
  • Spark Investment Management sold 15,000 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015, an estimated $39K.
  • Spark Investment Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q1 2014 and held it in 6 quarters.
  • Spark Investment Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $110K in Q2 2014.
  • 10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on Spark Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.